Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
BD

WKN: A2JMYV | ISIN: SE0011231158 | Ticker:
Lang & Schwarz
20.11.26 | 17:21
0,111 Euro
-2,42 % -0,003
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BOULE DIAGNOSTICS AB Chart 1 Jahr
5-Tage-Chart
BOULE DIAGNOSTICS AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,1060,11617:21

Aktuelle News zur BOULE DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.11.Boule Diagnostics AB: Boule Diagnostics AB resolves on a fully secured rights issue of approximately MSEK 93 with an over-allotment option of up to approximately MSEK 63 subject to approval by the Extraordinary General Meeting166NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND...
► Artikel lesen
04.11.Boule Diagnostics AB: Boule Diagnostics refocuses its operations on consumables, service and OEM - discontinues its instrument business181The Board of Directors of Boule Diagnostics AB (publ) ("Boule" or the "Company") has, following a strategic review, decided to discontinue the Company's instrument business. Boule will cease its own...
► Artikel lesen
23.10.Earnings Call: Boule Diagnostics bricht nach Umsatzeinbruch im dritten Quartal ein1
23.10.Boule Diagnostics AB: Boule Diagnostics Interim Report Q3 2026165Challenges in the instrument business but good stability in sales of consumables and the OEM business Quarter July-September 2026Net sales amounted to SEK 96.2 million (127.2), corresponding to a decrease...
► Artikel lesen
06.10.Boule Diagnostics AB: Boule Diagnostics Strengthens Long-Term Strategic Collaboration in India213Boule Diagnostics AB and Q-Line Biotech Limited have updated the licensing agreement between the two parties relating to diagnostic reagents, consumables and hematology analyzers for India market. The...
► Artikel lesen
31.08.Boule Diagnostics AB: Bulletin from the Extraordinary General Meeting August 31, 2026 in Boule Diagnostics304The Extraordinary General Meeting (the "EGM") resolved to approve a loan from one of the company's major shareholders, AB Grenspecialisten, in accordance with the Board of Directors' proposal. Complete...
► Artikel lesen
BOULE DIAGNOSTICS Aktie jetzt für 0€ handeln
17.07.Boule Diagnostics AB: Boule Diagnostics Interim Report Q2 2026245Quarter April-June 2026Net sales amounted to SEK 112.2 million (129.3), corresponding to a decrease of 13.3 percent. Organic sales growth amounted to -5.3 percent, currency effects amounted to -8.0...
► Artikel lesen
18.06.Boule Diagnostics AB: Boule Diagnostics appoints new Chief Executive Officer738The Board of Directors at Boule Diagnostics has today appointed Johan Folkunger, Chief Executive Officer, effective June 22, 2026. Johan Folkunger succeeds Simonetta Tumbiolo, who has been serving...
► Artikel lesen
29.05.Boule Diagnostics AB: Interim CEO at Boule Diagnostics248The board of directors at Boule Diagnostics has today appointed Simonetta Tumbiolo, currently Chief Commercial Officer Diagnostic, as Interim Chief Executive Officer, effective June 1 2026. As previously...
► Artikel lesen
13.05.Boule Diagnostics AB: Bulletin from the Annual General Meeting May 13, 2026 in Boule Diagnostics391At the Annual General Meeting 2026 (the "AGM") it was resolved to adopt the balance sheets and profit and loss statements for the parent company and the group for the financial year 2025. The AGM resolved...
► Artikel lesen
28.04.Boule Diagnostics AB: Boule Diagnostics Interim Report Q1 2026237Stable start to 2026 Quarter January-March 2026} Net sales amounted to SEK 101.6 million (112.9), corresponding to a decrease of 10.0 percent. Organic sales growth amounted to 3.0 percent, currency...
► Artikel lesen
11.02.Boule Diagnostics AB: Boule Diagnostics Year-end report 2025473Improved operating cash flowQuarter October-December 2025Net sales amounted to SEK 120.2 million (143.2), corresponding to a decrease of 16.0 percent. Organic sales growth amounted to -11.7 percent...
► Artikel lesen
30.12.25Boule Diagnostics AB: Boule Diagnostics appoints Michael af Winklerfelt as new CFO423Boule Diagnostics AB appoints Michael af Winklerfelt as new CFO, effective February 2026. Michael af Winklerfelt brings extensive international experience from senior finance roles in pharmaceuticals...
► Artikel lesen
22.12.25Boule Diagnostics AB: Boule Diagnostics Selected as One of Three Providers in Nationwide Hematology Tender in Italy254Boule Diagnostics, together with its Italian distribution partner A. Menarini Diagnostics, is proud to announce its selection as one of only three providers in a nationwide tender for hematology solutions...
► Artikel lesen
05.12.25Boule Diagnostics AB: Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Chapter280Boule Diagnostics today announced that Torben Nielsen, Chief Executive Officer, has decided to leave the company to pursue another professional opportunity. Under Torben's leadership, the company has...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1